World-wide Randomization Antibiotic Envelope Infection Prevention Trial (WRAP-IT)
Recruiting
1 years - 100 years
All
80 participants needed
1 Location
Brief description of study
This study is a single-blinded,randomized,prospective, multi-center clinical trial. The study will evaluate the ability of the TYRX absorable Antibacterial Envelope to reduce major cardiovascular implantable electronic device (CIED) infections. Patients undergoing CIED generator replacement, upgrade, revision or new biventricular defibrillator system will be randomized to receive the TYRX envelope or not to receive the TYRX envelope. A CIED is an implantable defibrillator or pacemaker.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: pacemakers, defibrillators
-
Age: 1 years - 100 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 822098
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or